VOTING AGREEMENTVoting Agreement • February 28th, 2003 • Novo Nordisk a S • Pharmaceutical preparations • California
REGISTRATION RIGHTS AGREEMENT dated as of September 17, 2014 among AFFIMED N.V. and THE SHAREHOLDERS PARTY HERETORegistration Rights Agreement • September 22nd, 2014 • Novo Nordisk a S • Pharmaceutical preparations • New York
THIS REGISTRATION RIGHTS AGREEMENT dated as of September 17, 2014 (this “Agreement”) by and among Affimed N.V., a Dutch public company with limited liability (the “Company”), and the shareholders listed on the signature pages hereto, as well as any Permitted Transferees (as defined below).
RECITALSStock Purchase Agreement • November 14th, 2001 • Novo Nordisk a S • Pharmaceutical preparations • California
Re: Confidentiality AgreementConfidentiality Agreement • November 24th, 2021 • Novo Nordisk a S • Pharmaceutical preparations
Novo Nordisk (referred to herein as “you or your”) has requested certain Evaluation Material (as defined below) from Dicerna Pharmaceuticals, Inc. (together with its subsidiaries, the “Company”) in connection with the evaluation, negotiation or completion of a potential negotiated transaction between you and the Company (the “Potential Transaction”). You and the Company are each individually referred to in this agreement (this “Agreement”) individually as a “Party” and, collectively, as the “Parties.”
MUTUAL CONFIDENTIALITY AGREEMENTMutual Confidentiality Agreement • November 24th, 2021 • Novo Nordisk a S • Pharmaceutical preparations • England
VOTING AGREEMENTVoting Agreement • September 29th, 2004 • Novo Nordisk a S • Pharmaceutical preparations • California
THIS VOTING AGREEMENT (the “Agreement”) is made and entered into as of this 28th day of September, 2004, by and among Novo Nordisk Delivery Technologies, Inc., a Delaware corporation (“Novo Nordisk Delivery Technologies, Inc.”) and those certain persons and entities listed on Exhibit A hereto (the “Shareholders”).
AMENDMENTMutual Confidentiality Agreement • November 24th, 2021 • Novo Nordisk a S • Pharmaceutical preparations
PENSION ADMINISTRATORS GROUP, INC. SALARY DEFERRAL RETIREMENT PLAN ADOPTION AGREEMENTSalary Deferral Retirement Plan Adoption Agreement • November 6th, 2008 • Novo Nordisk a S • Pharmaceutical preparations • Puerto Rico
AMENDMENT NO. 4 TO DEPOSIT AGREEMENTDeposit Agreement • November 29th, 2007 • Novo Nordisk a S • Pharmaceutical preparations
AMENDMENT No. 4 dated as of November 29, 2007 (the "Amendment") to the Deposit Agreement dated as of February 1, 1981, as amended as of September 10, 1984, as further amended and restated as of May 1, 1991 and as amended as of April 15, 1994, December 21, 1996 and April 4, 2001 (as so amended, the "Deposit Agreement"), among Novo Nordisk A/S, incorporated under the laws of Denmark (the "Company"), JPMorgan Chase Bank, N.A. (fka Morgan Guaranty Trust Company of New York), as depositary (the "Depositary"), and all Holders from time to time of American Depositary Receipts issued thereunder.
PENSION ADMINISTRATORS GROUP, INC. SALARY DEFERRAL RETIREMENT PLAN ADOPTION AGREEMENTAdoption Agreement • October 31st, 2017 • Novo Nordisk a S • Pharmaceutical preparations
This is the Adoption Agreement for the PENSION ADMINISTRATORS GROUP, INC. PROTOTYPE DEFINED CONTRIBUTION RETIREMENT PLAN PROGRAM (the “Plan”). You have selected the PENSION ADMINISTRATORS GROUP, INC. SALARY DEFERRAL RETIREMENT PLAN ADOPTION AGREEMENT. You may wish to consult with your tax and legal advisers before executing your Adoption Agreement. Failure to properly complete the Adoption Agreement may result in disqualification of the Plan.
CONFIDENTIAL DISCLOSURE AGREEMENTConfidentiality Agreement • November 24th, 2021 • Novo Nordisk a S • Pharmaceutical preparations • Delaware
THIS CONFIDENTIAL DISCLOSURE AGREEMENT (the “Agreement”) is made as of the last dated signature below (the “Effective Date”) by and between Dicerna Pharmaceuticals Inc., a Delaware corporation with a business address at 33 Hayden Avenue, Lexington, Massachusetts 02421 (Tel: 617-621-8097; Fax: 6l7-252-0976)(“Dicerna”), and Novo Nordisk A/S, with a business address at Novo Alle I, 2880 Bagsvaerd, Denmark (“COMPANY”) (each a “Party” and, collectively, the “Parties”).
The attached draft shall not be considered final as to any party unless executed and delivered by such party. AMENDED AND RESTATED STOCK PURCHASE AGREEMENT ARADIGM CORPORATIONStock Purchase Agreement • September 29th, 2004 • Novo Nordisk a S • Pharmaceutical preparations • California
THIS AMENDED AND RESTATED STOCK PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of ________ __, 2004, by and among ARADIGM CORPORATION, a corporation duly organized and existing under the law of the State of California(“Aradigm”), Novo Nordisk A/S, a company organized and existing under the Law of Denmark (“NovoNordisk”) and NOVO NORDISK PHARMACEUTICALS, INC. a corporation duly organized and existing under the law of the State of Delaware (“Novo Nordisk Pharmaceuticals, Inc.”)
The attached draft shall not be considered final as to any party unless executed and delivered by such party. RESTRUCTURING AGREEMENT dated as of September 28, 2004 among ARADIGM CORPORATION NOVO NORDISK A/S and NOVO NORDISK DELIVERY TECHNOLOGIES, INC.Restructuring Agreement • September 29th, 2004 • Novo Nordisk a S • Pharmaceutical preparations • New York
AGREEMENT dated as of September 28, 2004 by and among Aradigm Corporation, a corporation duly organized and existing under the law of the State of California (“Aradigm”), Novo Nordisk A/S, a company duly organized and existing under the law of Denmark (“Novo Nordisk”) and Novo Nordisk Delivery Technologies, Inc., a corporation duly organized and existing under the law of the State of Delaware (“Novo Nordisk Delivery Technologies, Inc.”). Capitalized terms used herein and not otherwise defined shall have the respective meanings assigned to them in Article 1.
